LRMR Annual Cash & Cash Equivalents
$26.75 M
-$76.00 K-0.28%
31 December 2023
Summary:
As of January 23, 2025, LRMR annual cash & cash equivalents is $26.75 million, with the most recent change of -$76.00 thousand (-0.28%) on December 31, 2023. During the last 3 years, it has fallen by -$41.40 million (-60.75%). LRMR annual cash & cash equivalents is now -61.84% below its all-time high of $70.10 million, reached on December 31, 2021.LRMR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LRMR Quarterly Cash And Cash Equivalents
$35.07 M
+$2.76 M+8.53%
30 September 2024
Summary:
As of January 23, 2025, LRMR quarterly cash and cash equivalents is $35.07 million, with the most recent change of +$2.76 million (+8.53%) on September 30, 2024. Over the past year, it has increased by +$2.76 million (+8.53%). LRMR quarterly cash and cash equivalents is now -68.88% below its all-time high of $112.67 million, reached on June 30, 2020.LRMR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LRMR Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.3% | +8.5% |
| 3 y3 years | -60.8% | +8.5% |
| 5 y5 years | +2551.0% | +8.5% |
LRMR Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.8% | at low | -68.6% | +77.7% |
| 5 y | 5-year | -61.8% | +2551.0% | -68.9% | +3375.4% |
| alltime | all time | -61.8% | +2551.0% | -68.9% | +3375.4% |
Larimar Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $35.07 M(+8.5%) |
| June 2024 | - | $32.31 M(-70.7%) |
| Mar 2024 | - | $110.13 M(+311.7%) |
| Dec 2023 | $26.75 M(-0.3%) | $26.75 M(-30.9%) |
| Sept 2023 | - | $38.72 M(-58.9%) |
| June 2023 | - | $94.32 M(-15.4%) |
| Mar 2023 | - | $111.52 M(+315.7%) |
| Dec 2022 | $26.82 M | $26.82 M(-68.8%) |
| Sept 2022 | - | $86.05 M(+336.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $19.74 M(-68.5%) |
| Mar 2022 | - | $62.56 M(-10.7%) |
| Dec 2021 | $70.10 M(+2.9%) | $70.10 M(-2.0%) |
| Sept 2021 | - | $71.53 M(+1.3%) |
| June 2021 | - | $70.63 M(+13.6%) |
| Mar 2021 | - | $62.19 M(-8.7%) |
| Dec 2020 | $68.15 M(+6654.0%) | $68.15 M(-32.7%) |
| Sept 2020 | - | $101.31 M(-10.1%) |
| June 2020 | - | $112.67 M(>+9900.0%) |
| Dec 2019 | $1.01 M | $1.01 M |
FAQ
- What is Larimar Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Larimar Therapeutics?
- What is Larimar Therapeutics annual cash & cash equivalents year-on-year change?
- What is Larimar Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Larimar Therapeutics?
- What is Larimar Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Larimar Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of LRMR is $26.75 M
What is the all time high annual cash & cash equivalents for Larimar Therapeutics?
Larimar Therapeutics all-time high annual cash & cash equivalents is $70.10 M
What is Larimar Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, LRMR annual cash & cash equivalents has changed by -$76.00 K (-0.28%)
What is Larimar Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LRMR is $35.07 M
What is the all time high quarterly cash and cash equivalents for Larimar Therapeutics?
Larimar Therapeutics all-time high quarterly cash and cash equivalents is $112.67 M
What is Larimar Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, LRMR quarterly cash and cash equivalents has changed by +$2.76 M (+8.53%)